Development of a refined database of mammalian relative potency estimates for dioxin-like compounds.
about
The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compoundsEvaluation of relative effect potencies (REPs) for dioxin-like compounds to derive systemic or human-specific TEFs to improve human risk assessmentEvaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States population.Mathematical model developed for environmental samples: prediction of GC/MS dioxin TEQ from XDS-CALUX bioassay dataAddendum to: Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States population.Developing tools for risk assessment in protected species: Relative potencies inferred from competitive binding of halogenated aromatic hydrocarbons to aryl hydrocarbon receptors from beluga (Delphinapterus leucas) and mouse.Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice.Applying the maximum cumulative ratio methodology to biomonitoring data on dioxin-like compounds in the general public and two occupationally exposed populations.Determination of in vitro relative potency (REP) values for mono-ortho polychlorinated biphenyls after purification with active charcoal.Advances in analytical techniques for polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and dioxin-like PCBsAssessment of the Polychlorinated Biphenyl (PCB) Occurrence in Copper Sulfates and the Influential Role of PCB Levels on Grapes.Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context.Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on two thyroid outcomes.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Learning behavior in rat offspring after in utero and lactational exposure to either TCDD or PCB126Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes.Organochlorine pollutants and female fertility: a systematic review focusing on in vitro fertilization studies.An improved method for calculating toxicity-based pollutant loads: Part 1. Method development.An improved method for calculating toxicity-based pollutant loads: Part 2. Application to contaminants discharged to the Great Barrier Reef, Queensland, Australia.Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on cytochrome P450 1A1 and 1B1 gene expression in blood.Simple and rapid yeast reporter bioassay for dioxin screening: evaluation of the dioxin-like compounds in industrial and municipal waste incineration plants.Opinion of the Scientific Panel on Plant Protection products and their Residues to evaluate the suitability of existing methodologies and, if appropriate, the identification of new approaches to assess cumulative and synergistic risks from pestici...Aryl hydrocarbon receptor-based bioassays for dioxin detection: Thinking outside the box.Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female rats after a single oral dose.Incidence of jaw lesions and activity and gene expression of hepatic P4501A enzymes in mink (Mustela vison) exposed to dietary 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran.Risk assessment of environmental mixture effects
P2860
Q24657959-7ACB323A-3B18-4BBF-897E-B907FE56F3BAQ26751039-1194EFBF-4772-4FD6-991F-A3A3092EFB40Q31047999-5026E90F-01BE-4323-9A4C-2DD439CF4D3BQ31118701-811DE786-C697-47E2-B4F7-F5AAD18CF201Q31150681-1A4C051A-0170-4040-A9CF-E1FCBC42AA51Q33668017-97022974-8C13-4621-A459-B02DDD1F744CQ34200656-DF9FD08C-4509-4D3E-BA35-1C4B29FD05D1Q34332629-B39A5439-BED1-4452-AA2E-93949D117DA2Q34544385-FA2B1711-58B3-41BA-AAFB-F4E736441656Q35574602-BF3A408E-B477-46D9-A2F5-FB765DD0B52DQ35866707-E5FCBCB0-FA32-4D79-A442-4FE496DEB0DFQ36447531-D9CDA462-5FD1-4374-BD13-237E6F26863EQ37072589-13ED1926-A3E5-4D11-B50C-AB6860E4DD92Q37121662-AD497A8B-6FB2-4EBC-A778-EC8509372F16Q37232278-A98609E6-A506-49C3-BCFD-1CF4772A487AQ37278918-D6A32AD0-ED35-4ABD-A3D6-FD6B70ECCD75Q38010673-2F787641-B2A5-47DE-9DAF-F0C723ECB204Q39298476-B4F19854-0C6A-4E52-B0E3-927EC200A9B6Q39298839-2E71DE80-501C-4A6E-AD50-5B9B6DA35342Q39428475-2D87121C-3FC2-47FF-9670-063439A5E9D6Q43350447-E5F69040-D9F1-44BF-8ABC-9586268D9EFAQ47145464-DDD74F84-84F9-49B2-ABDE-D7F9170A233CQ47254625-4119D29C-F850-4C6C-B566-05300BB64DC8Q51174250-4C9CC7DE-6443-43C5-81B3-632022AB28B7Q51320210-AB773633-DF3F-4051-98CE-2F6634CC81A8Q57157856-B43436C3-9DA7-457D-8574-B2C536C11119
P2860
Development of a refined database of mammalian relative potency estimates for dioxin-like compounds.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Development of a refined datab ...... tes for dioxin-like compounds.
@ast
Development of a refined datab ...... tes for dioxin-like compounds.
@en
type
label
Development of a refined datab ...... tes for dioxin-like compounds.
@ast
Development of a refined datab ...... tes for dioxin-like compounds.
@en
prefLabel
Development of a refined datab ...... tes for dioxin-like compounds.
@ast
Development of a refined datab ...... tes for dioxin-like compounds.
@en
P2093
P2860
P50
P356
P1476
Development of a refined datab ...... ates for dioxin-like compounds
@en
P2093
Brent Finley
Laurie C Haws
Steave H Su
William H Farland
P2860
P356
10.1093/TOXSCI/KFI294
P577
2005-08-24T00:00:00Z